
    
      This prospective study was designed to evaluate the feasibility and effectiveness of the use
      of Everolimus in the minimization and possible suspension of calcineurin inhibitors in adult
      liver transplant patients. The study will take into account a control group (standard
      immunosuppression with tacrolimus and steroids) after induction with anti-IL2 Antibodies.
    
  